SWOG clinical trial number
S0713

A Phase II Study of Oxaliplatin, Capecitabine, Cetuximab and Radiation in Pre-operative Therapy of Rectal Cancer

94% Accrual
Accrual
94%
Closed
Phase
94% Accrual
Accrual
94%
Published
Abbreviated Title
Ph II Rectal Pre-Operative ChemoRT
Activated
02/01/2009
Closed
04/15/2013
Participants
NCORP, Members, Medical Oncologists, Radiation Oncologists, Surgeons, Affiliates

Research committees

Gastrointestinal Cancer

Treatment

Oxaliplatin Capecitabine Cetuximab